New fluid lens could sharpen vision after cataract surgery

NCT ID NCT05317728

Ongoing Disease control Sponsor: Alcon Research Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new type of lens implant for people having cataract surgery. The lens uses fluid to adjust focus, aiming to improve vision compared to a standard fixed-focus lens. About 175 participants will receive either the new lens or a standard one, and their vision and any complications will be tracked over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Fluid accommodating intraocular lens (IOL) implant
What this could lead to: If it works, this lens could provide better distance vision after cataract surgery than standard lenses, reducing the need for glasses.
What could go wrong: This is a relatively small, early-stage study (175 participants) comparing a new device to an existing one. The new lens may not show significant improvement or could have unexpected side effects like any surgical implant.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cataract

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CATARACT

Contacts and locations

Locations

Asociación Para Evitar la Ceguera en México

Mexico City, 04030, Mexico
Centro de Retina Medica y Quirurgica SC

Zapopan, Jalisco, 45116, Mexico
Clinica 20/20

San José, Costa Rica
Laser Center SA

Santo Domingo, 10124, Dominican Republic
Panama Eye Center

Panama City, Panama
Salauno Salud SAPI de CV

Mexico City, 06600, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.